New treatment option for Vestibular Hypofunction
Official title Visual Influences on Vestibular Adaptation
ClinicalTrials.gov ID: NCT07380256
What this study is testing
- What it's testing
- The goal of this study is to learn whether a balance-training exercise called incremental vestibulo-ocular reflex adaptation (IVA) is safe and effective for adults with vision impairments, with or without additional vestibular (inner-ear balance) problems. The main questions it aims to answer are: Does IVA cause only mild, temporary symptoms and no serious adverse events?
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 60
You may be able to join if
- For All Participants (All Groups)
- Age 18 to 60 years
- Able to provide informed consent Group-Specific
- Group 1: Abnormal Uncorrected Static Visual Acuity (No Vestibular Hypofunction) Normal peripheral vestibular function
- Group 2: Abnormal Uncorrected Static Visual Acuity + peripheral Vestibular Hypofunction
You likely can't join if
- Diagnosis of fluctuating vestibular disorders (e.g., benign paroxysmal positional vertigo)
- Neurologic conditions (e.g., multiple sclerosis), dementia,
- Alcohol or drug abuse,
- A major psychiatric disorder (e.g., schizophrenia),
- Pain that limits cervical spine range of motion by \>50% or that results in an -altered gait pattern.
See the full eligibility criteria
- For All Participants (All Groups)
- Age 18 to 60 years
- Able to provide informed consent Group-Specific
- Group 1: Abnormal Uncorrected Static Visual Acuity (No Vestibular Hypofunction) Normal peripheral vestibular function
- Group 2: Abnormal Uncorrected Static Visual Acuity + peripheral Vestibular Hypofunction
- Group 3: Binocular Vision Abnormalities (No Vestibular Hypofunction) Normal peripheral vestibular function
- Group 4: Binocular Vision Abnormalities + peripheral Vestibular Hypofunction Individuals who have abnormal static visual acuity, a binocular vision abnormality (ocular misalignment, convergence insufficiency), and...
- Abnormal Static Visual Acuity: Uncorrected visual acuity (head is still) ≥0.30 logMAR in both eyes.
- Unilateral Vestibular Hypofunction: 60 ms VOR gain \<0.80 unilaterally for the lateral semicircular canal.
- Bilateral Vestibular Hypofunction: 60 ms VOR gain \<0.80 bilaterally for the lateral semicircular canals.
- Normal Vestibular Function: 60 ms VOR gain of 0.80 to 1.20 bilaterally for the lateral semicircular canals.
- Convergence Insufficiency: ≥6 cm near point of convergence.
- Ocular Misalignment: ≥4 prism diopters of manifest deviation of the eyes (tropia) on cover/uncover testing.
- Diagnosis of fluctuating vestibular disorders (e.g., benign paroxysmal positional vertigo)
- Neurologic conditions (e.g., multiple sclerosis), dementia,
- Alcohol or drug abuse,
- A major psychiatric disorder (e.g., schizophrenia),
- Pain that limits cervical spine range of motion by \>50% or that results in an -altered gait pattern.
The study team makes the final eligibility decision.
Where it's taking place
- Atlanta, Georgia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 60 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Atlanta, Georgia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.